2. Academic Validation
  3. Metronomic Chemotherapy Induces Metabolic Reprogramming in Cancer Cells That Modulates Mature Regulatory Dendritic Cell Function to Stimulate Antitumor Immunity

Metronomic Chemotherapy Induces Metabolic Reprogramming in Cancer Cells That Modulates Mature Regulatory Dendritic Cell Function to Stimulate Antitumor Immunity

  • Cancer Res. 2026 Jun 1;86(11):2793-2809. doi: 10.1158/0008-5472.CAN-25-3669.
Zhenji Deng # 1 2,  Chuqing Zhang # 1 2,  Hanmiao Wei # 1 2,  Zhihao Hu # 3 4,  Guanxiang Hua 1 2,  Zhe Li 1 2,  Jiawei Wu 1 5,  Tingxiang He 1 2,  Yunlong Wang 1 2,  Yinglin Cai 1 2,  Liufen Long 1,  Yuhao Li 1,  Guibo Li 3 6,  Yupei Chen 1 2,  Chen Wei 3 7,  Jun Ma 1 2 8,  Xiaoyu Liang 1 2
Affiliations

Affiliations

  • 1 State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • 2 Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • 3 BGI Research, Chongqing, China.
  • 4 College of Life Sciences, University of Chinese Academy of Sciences, Beijing, China.
  • 5 Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • 6 State Key Laboratory of Genome and Multi-omics Technologies, BGI Research, Shenzhen, China.
  • 7 Department of Bioinformatics, The Basic Medical School of Chongqing Medical University, Chongqing, China.
  • 8 Department of Radiation Oncology, Cancer Treatment Center, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.
  • # Contributed equally.
PMID: 41784618 DOI: 10.1158/0008-5472.CAN-25-3669
Abstract

The efficacy of chemotherapy depends partly on the ability to induce antitumor immunity. A better understanding of how different chemotherapy modes mediate antitumor immune responses could provide insights for developing optimized treatment modalities. In this study, we demonstrated that metronomic chemotherapy (MC), a mode of frequent and regular administration of chemotherapeutic drugs at lower doses, induced robust CD8+ T cell-dependent antitumor immune memory by modulating the activity of mature regulatory dendritic cells (mregDCs). Mechanistically, by imposing more frequent stress on tumor cells, MC induced sustained activation of activating transcription factor 4 (ATF4), leading to metabolic reprogramming of tumor cells and enhanced asparagine (Asn) release into the tumor microenvironment. Functioning as a ligand, Asn directly bound to Axl receptor tyrosine kinase (Axl) on mregDCs, inhibiting Axl kinase activity and downregulating programmed death-ligand 1 (PD-L1) expression. Consequently, mregDCs with reduced PD-L1 expression fostered the generation of more memory-like CD8+ T cells during their interactions. Overall, this study unveils critical biological events driving antitumor immune memory formation under therapeutic stress and provides a rationale for optimizing chemotherapy modalities.

Significance: Metronomic chemotherapy enhances antitumor immunity by rewiring tumor cell metabolism to reprogram mature regulatory dendritic cells and foster memory CD8+ T-cell formation, providing insights for enhancing treatment efficacy.

Figures
Products